Commercialization: Page
-
PharmaVoice Team/PharmaVoice
Thomas Ebeling: A Leader on a Mission
A Leader on a Mission BY KIm Ribbink With a strong consumer background, Thomas Ebeling, CEO of Novartis Pharma AG and head of Novartis’ pharmaceuticals division worldwide, has the company positioned for growth. T homas Ebeling’s focus is to make sure Novartis is considered best in class by both d...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Ron Pantello THE HEALTHCARE COMMUNICATIONs INDUSTRY: ON THE BRINK OF FINANCIAL DISASTER? As many of us are witnessing, the healthcare communications industry is under siege. Economic constraints are so severe that the very existence of the industry as we know it is threatened. Yet ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma trax Sales, marketing, And R&D Trends affecting the healthcare industry New Drug Commercialization Costs Lead to Blockbuster Model’s End The high cost of commercialization is leading to the demise of the pharma industry’s blockbuster approach to developing new drugs, according to a stu...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
What’s on your mind opinions Year in Review Continuing regulatory scrutiny, an economy yet to rebound, and evolving world events are some of the hallmarks for 2003. As 2004 approaches, PharmaVOICE asked how the trends and challenges of 2003 have impacted your business and how these market factors...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
January 2004 PharmaVOICE The forum for the industry executive portfolio management Strategies improving patient compliance with Dorothy Smith Device and Diagnostic Marketing www.pharmavoice.com Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New healthcare-related products, services, and companies Market Measures/Cozint Forms Emerging Markets Team Group to focus exclusively on the market research needs of emerging pharma companies. Realizing that smaller and specialized companies involved in the healthcare field have unique requireme...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
January 10-11 Clarifying the Regulatory Framework of Pharmaceutical Marketing Philadelphia For more information, contact Anne Marie Coluccio, PTi international, at 212-661-3500 ext. 3229, e-mail [email protected], or visit pti-international.com. January 24-25 Manage the Cost of Spec...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single brand...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
To Err is Human How Personal Health Records Can help It seems that a day doesn’t go by without hearing about health information technology (HIT). The healthcare system often is touted as one of our nation’s worst big-industry offenders when it comes to implementing HIT. This lack of HIT is to bla...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Raise your Voice Letters Medicare Drug Benefit – A Terrible Mistake The Medicare prescription drug bill voted on by Congress in November 2003 was a terrible mistake that will dearly cost our children and grandchildren. This was not a Medicare reform bill. This was barely a Medicare prescription d...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter From the Editor
Letter From The Editor More than 40% of executives recently surveyed by Datamonitor believe their companies are failing to commit adequate time and resources to portfolio management and futhermore, 25% believe their organizations have little ability to implement and execute portfolio management e...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
on the cover Prioritizing the pipeline: The role of portfolio management Increased pressures on the pharmaceutical industry ó from shrinking pipelines to rising costs, reimbursement issues, and regulatory pressures ó mean companies have to find ways to focus on the projects that will meet corpora...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma trax Sales, marketing, And R&D Trends affecting the healthcare industry Approval of Innovative Drugs Increase in 2003 An increase in overall drug and biologic approvals for calendar year 2003 has been reported by the Food and Drug Administration (FDA). In addition, regulatory officials...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Lost in Translation: Tackling the Barriers to Hispanic Good Health
Lost in Translation Tackling the Barriers to Hispanic Good Health By Kim Ribbink The significance of the growing Hispanic market to pharmaceutical companies cannot be overemphasized. Hispanics are the fastest-growing multicultural group in the United States. According to U.S. Census Bureau statis...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s new New healthcare-related products, services, and companies RxPedite Established to Provide Solutions to Emerging pharma and Biotech Companies Cardinal Health and inChord joint venture offers a full range of of launch-support services. RxPedite LLC has been established to provide comprehe...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Technology Makes CRM Possible
Technology Makes CRM Possible By Denise Myshko The lifeblood of customer relationship management (CRM) is data. Many pharmaceutical companies are investing in CRM technology projects to capture and better analyze data related to their customers. At its most basic level, CRM is the application of ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Richard W. Ashley James White Abbott Laboratories Names New Executives Abbott Laboratories has named Richard W. Ashley to the new position of executive VP of corporate development. Abbott, Abbott Park, Ill., is a global, broad-based healthcare company devoted to the discovery, develop...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
With an estimated $40 million spent in 2002 on CRM products and services, CRM is becoming the leading driver of technology spend and strategic technology focus in the pharmaceutical industry. Industry experts, however, who spoke with PharmaVoice say more often than not, CRM technology projects fa...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
E-Media New electronic and web-based applications, sites, and technologies NoInk Communications has released Pharma-SalesAccelerator, a new suite of applications specifically designed to improve productivity and increase performance of pharmaceutical sales organizations. NoInk partnered with Pedi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Eileen M. Lach Wyeth Fills VP, Associate General Counsel Position Wyeth has promoted Eileen M. Lach to the position of VP, corporate secretary, and associate general counsel. Wyeth, Madison, N.J., is a pharma...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
2nd Chances
2nd Chances By Elisabeth Pena For products that are not performing to expectations, a relaunch can revitalize a stale brand, highlight new clinical evidence, or give a product another chance to reach the patients it was designed to treat. With each therapy that a pharma company produces, the goal...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Global Brand Development: Debunking The Myths and Understanding The Realities
Global Brand Development Debunking The Myths and Understanding The Realities These are not easy times in the pharmaceutical industry, particularly given pressures to increase shareholder return and value, increased focus on price and generic use, a drop off in new chemical entity approvals, and i...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma trax Sales, marketing, And R&D Trends affecting the healthcare industry World Pharma Market Continues to Grow Amid Shifting Trends and Emerging Markets Though the pharmaceutical industry remains one of the most profitable and stable industries, several broad variables are leading to fu...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. – in combination or as single brand...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review For Art’s Sake each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. – in combination or ...
By PharmaVoice Team • Jan. 2, 2008
Previous
